First Manhattan

First Manhattan’s Esperion Therapeutics ESPR Stock Holding History

First Manhattan’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,000	Closed	-$2.68K	–	858
2024 Q1	$2.68K	Buy	+1,000	New	+$2.43K	﹤0.01%	1263
2022 Q4	–	Sell	-340	Closed	-$2K	–	1721
2022 Q3	$2K	Sell	340 -70	-17%	-$481	﹤0.01%	1415
2022 Q2	$2K	Hold	410	–	–	﹤0.01%	1427
2022 Q1	$1K	Hold	410	–	–	﹤0.01%	1530
2021 Q4	$2K	Hold	410	–	–	﹤0.01%	1470
2021 Q3	$4K	Hold	410	–	–	﹤0.01%	1424
2021 Q2	$8K	Hold	410	–	–	﹤0.01%	1311
2021 Q1	$11K	Hold	410	–	–	﹤0.01%	1216
2020 Q4	$10K	Hold	410	–	–	﹤0.01%	1145
2020 Q3	$15K	Hold	410	–	–	﹤0.01%	1070
2020 Q2	$21K	Hold	410	–	–	﹤0.01%	1020
2020 Q1	$12K	Buy	+410	New	+$21.6K	﹤0.01%	1102

Other funds holding ESPR

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return